Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -487.90% is 513% below its 5-year average of -79.60%, near the low end of its 5-year range (-487.90%–-0.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.28% below its 12-month average of -335.83%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -487.90%.
RETURN ON EQUITY (ROE)
-487.90%
RETURN ON EQUITY (ROE) AVG TTM
-335.83%
RETURN ON EQUITY (ROE) AVG 3Y
-156.07%
RETURN ON EQUITY (ROE) AVG 5Y
-79.60%
RETURN ON EQUITY (ROE) AVG 10Y
-112.71%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-45.28%
CURRENT VS 3Y AVG
-212.62%
CURRENT VS 5Y AVG
-512.95%
CURRENT VS 10Y AVG
-332.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-1061.39%
vs the sector median at left
Rein Therapeutics Inc.
Market Cap
$23.09M
Return on Equity (ROE)
-487.90%
TTM Avg
-335.83%
3Y Avg
-156.07%
5Y Avg
-79.60%
Market Cap
$23.15M
Return on Equity (ROE)
-0.80%
TTM Avg
-5.04%
3Y Avg
68.38%
5Y Avg
100.94%
Market Cap
$22.29M
Return on Equity (ROE)
-421.06%
TTM Avg
-298.11%
3Y Avg
-181.82%
5Y Avg
-125.27%
Market Cap
$24.01M
Return on Equity (ROE)
N/A
TTM Avg
-294.82%
3Y Avg
229.70%
5Y Avg
122.55%
Market Cap
$24.18M
Return on Equity (ROE)
-76.82%
TTM Avg
-235.52%
3Y Avg
-335.24%
5Y Avg
-272.42%
Market Cap
$21.90M
Return on Equity (ROE)
-40.40%
TTM Avg
-55.95%
3Y Avg
-53.10%
5Y Avg
-83.38%
Market Cap
$21.60M
Return on Equity (ROE)
-260.37%
TTM Avg
-164.08%
3Y Avg
-188.26%
5Y Avg
-64.22%
Market Cap
$24.64M
Return on Equity (ROE)
-140.55%
TTM Avg
-62.02%
3Y Avg
-44.98%
5Y Avg
-43.41%
Market Cap
$20.99M
Return on Equity (ROE)
-313.46%
TTM Avg
-251.20%
3Y Avg
-178.74%
5Y Avg
-144.62%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $23.09M | -487.90% | -335.83% | -156.07% | -79.60% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.15M | -0.80% | -5.04% | 68.38% | 100.94% |
| LeonaBio, Inc. (LONA)vs › | $22.29M | -421.06% | -298.11% | -181.82% | -125.27% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.01M | N/A | -294.82% | 229.70% | 122.55% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | -76.82% | -235.52% | -335.24% | -272.42% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -40.40% | -55.95% | -53.10% | -83.38% |
| Modular Medical, Inc. (MODD)vs › | $21.60M | -260.37% | -164.08% | -188.26% | -64.22% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.64M | -140.55% | -62.02% | -44.98% | -43.41% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | -313.46% | -251.20% | -178.74% | -144.62% |
| InspireMD, Inc. (NSPR)vs › | $25.76M | -122.19% | -88.53% | -83.45% | -77.50% |
ROE
-487.9%
ROA
-75.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -487.90% |
| 2026-03-31 | -433.16% |
| 2025-12-31 | -294.78% |
| 2025-09-30 | -127.48% |
| 2024-12-31 | -86.12% |
| 2024-09-30 | -11.69% |
| 2024-06-30 | -0.05% |
| 2024-03-31 | -0.04% |
| 2023-12-31 | -69.55% |
| 2023-09-30 | -83.32% |
| 2023-06-30 | -122.68% |
| 2023-03-31 | -165.95% |
| 2022-12-31 | -146.75% |
| 2022-09-30 | -130.34% |
| 2022-06-30 | -104.54% |
| 2022-03-31 | -76.47% |
| 2021-12-31 | -59.59% |
| 2021-09-30 | -48.62% |
| 2021-06-30 | -40.41% |
| 2021-03-31 | -34.82% |
| 2020-12-31 | -173.96% |
| 2020-09-30 | -187.80% |
| 2020-06-30 | -156.85% |
| 2020-03-31 | -295.87% |
| 2019-12-31 | -183.01% |
| 2019-09-30 | -127.84% |
| 2019-06-30 | -96.23% |
| 2019-03-31 | -242.64% |
| 2018-12-31 | -160.95% |
| 2018-09-30 | -120.54% |
| 2018-06-30 | -91.89% |
| 2018-03-31 | -62.56% |
| 2017-12-31 | -47.29% |
| 2017-09-30 | -37.36% |
| 2017-03-31 | -131.34% |
